HIV and AIDS Trial, Recruiting (NCT06883097)

HIV and AIDS Trial, Recruiting NCT06883097 Sponsor: Wake Forest University Health Sciences Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06883097 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been smoking cigarettes every day for the past 30 days
You are willing to share your HIV status with the study team
You are 18 years old or older
You want to quit smoking
You are willing to use nicotine replacement therapy (such as patches or gum) and a doctor has confirmed it is safe for you to do so
You are currently receiving medical care for HIV
You own a smartphone that runs on Android or Apple iOS

Who may not be able to join:

You are currently experiencing a severe mental health crisis or it would not be safe for you to take part in the study
You are pregnant or planning to become pregnant in the next 6 months
You are already taking part in another program or receiving counseling to help you stop smoking
You have a medical condition or take a medication that could put your safety at risk during the study (the study doctors will assess this)
You are not able to speak and write fluently in English
You have difficulties with hearing, understanding, vision, speech, or movement that would prevent you from taking part in the study

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Roger Vilardaga Viera, Ph.D., Wake Forest University Health Sciences

Phone: 336-716-1495

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06883097

Sponsor: Wake Forest University Health Sciences

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: 336-716-1495

More information: https://clinicaltrials.gov/study/NCT06883097

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been smoking cigarettes every day for the past 30 days
You are willing to share your HIV status with the study team
You are 18 years old or older
You want to quit smoking
You are willing to use nicotine replacement therapy (such as patches or gum) and a doctor has confirmed it is safe for you to do so
You are currently receiving medical care for HIV
You own a smartphone that runs on Android or Apple iOS

Who may not be able to join:

You are currently experiencing a severe mental health crisis or it would not be safe for you to take part in the study
You are pregnant or planning to become pregnant in the next 6 months
You are already taking part in another program or receiving counseling to help you stop smoking
You have a medical condition or take a medication that could put your safety at risk during the study (the study doctors will assess this)
You are not able to speak and write fluently in English
You have difficulties with hearing, understanding, vision, speech, or movement that would prevent you from taking part in the study

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Wake Forest University Health Sciences

Registry

ClinicalTrials.gov

Start date

18 August 2025

Est. completion

1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Biochemically verified 7-day point prevalence abstinence at 6, 12, 18, and 24-weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov